U.S. flag

An official website of the United States government

NM_000275.3(OCA2):c.2330G>A (p.Cys777Tyr) AND Tyrosinase-positive oculocutaneous albinism

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
May 6, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002470881.4

Allele description [Variation Report for NM_000275.3(OCA2):c.2330G>A (p.Cys777Tyr)]

NM_000275.3(OCA2):c.2330G>A (p.Cys777Tyr)

Gene:
OCA2:OCA2 melanosomal transmembrane protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q13.1
Genomic location:
Preferred name:
NM_000275.3(OCA2):c.2330G>A (p.Cys777Tyr)
HGVS:
  • NC_000015.10:g.27851390C>T
  • NG_009846.1:g.252923G>A
  • NM_000275.3:c.2330G>AMANE SELECT
  • NM_001300984.2:c.2258G>A
  • NP_000266.2:p.Cys777Tyr
  • NP_001287913.1:p.Cys753Tyr
  • NC_000015.9:g.28096536C>T
  • NM_000275.2:c.2330G>A
Protein change:
C753Y
Links:
dbSNP: rs776814755
NCBI 1000 Genomes Browser:
rs776814755
Molecular consequence:
  • NM_000275.3:c.2330G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300984.2:c.2258G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Tyrosinase-positive oculocutaneous albinism (OCA2)
Synonyms:
ALBINISM II; Albinism 2; Albinoidism; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008746; MedGen: C0268495; Orphanet: 79432; OMIM: 203200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002767262Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 6, 2021)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV003804559Laboratoire de Génétique Moléculaire, CHU Bordeaux
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Gargiulo A, Testa F, Rossi S, Di Iorio V, Fecarotta S, de Berardinis T, Iovine A, Magli A, Signorini S, Fazzi E, Galantuomo MS, Fossarello M, Montefusco S, Ciccodicola A, Neri A, Macaluso C, Simonelli F, Surace EM.

Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1281-9. doi: 10.1167/iovs.10-6091. Print 2011 Mar.

PubMed [citation]
PMID:
20861488
PMCID:
PMC3101674

Clinical utility gene card for: Oculocutaneous albinism.

Grønskov K, Brøndum-Nielsen K, Lorenz B, Preising MN.

Eur J Hum Genet. 2014 Aug;22(8). doi: 10.1038/ejhg.2013.307. Epub 2014 Feb 12. No abstract available.

PubMed [citation]
PMID:
24518832
PMCID:
PMC4350605
See all PubMed Citations (6)

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002767262.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with brown oculocutaneous albinism and oculocutaneous, type II albinism (MIM#203200). (I) 0106 - This gene is associated with autosomal recessive disease. A single variant has been reported in two families with dominant oculocutaneous albinism (PMID: 32741191). (I) 0115 - Variants in this gene causing oculocutaneous albinism are known to have variable expressivity (PMID: 24518832). (I) 0200 - Variant is predicted to result in a missense amino acid change from cysteine to tyrosine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a condition (8 heterozygotes, 0 homozygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated transmembrane helix within the permease P domain (NCBI). (I) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. An alternative change p.(Cys777Arg) has been reported in a heterozygous patient with albinism (PMID: 20861488). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported twice as likely pathogenic (ClinVar), and has been observed in a heterozygous patient with albinism (PMID: 28976636). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1206 - This variant has been shown to be paternally inherited (LABID). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Laboratoire de Génétique Moléculaire, CHU Bordeaux, SCV003804559.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024